Hap Trading, LLC Jounce Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 12, 2022	SELL	$6.01 - $8.54 $71,519 - $101,625	-11,900 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$7.11 - $9.64 $84,609 - $114,716	11,900 New	11,900 $15,000
Q1 2021 May 14, 2021	SELL	$6.73 - $13.87 $74,030 - $152,570	-11,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.37 - $10.33 $70,070 - $113,630	11,000 New	11,000 $16,000
Q3 2020 Nov 13, 2020	SELL	$4.58 - $10.95 $76,028 - $181,770	-16,600 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$4.17 - $7.58 $69,222 - $125,828	16,600 New	16,600 $7,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.